Jump Financial LLC reduced its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 85.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,284 shares of the company's stock after selling 13,797 shares during the period. Jump Financial LLC's holdings in DaVita were worth $239,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DVA. Gateway Advisory LLC acquired a new stake in DaVita during the 4th quarter valued at $239,000. Teacher Retirement System of Texas raised its holdings in shares of DaVita by 1,048.2% in the fourth quarter. Teacher Retirement System of Texas now owns 76,700 shares of the company's stock valued at $8,035,000 after buying an additional 70,020 shares during the last quarter. Donoghue Forlines LLC lifted its position in DaVita by 1.4% during the 4th quarter. Donoghue Forlines LLC now owns 13,144 shares of the company's stock worth $1,377,000 after buying an additional 184 shares in the last quarter. Mount Lucas Management LP acquired a new stake in DaVita in the 4th quarter valued at about $2,177,000. Finally, Principal Securities Inc. acquired a new position in shares of DaVita during the fourth quarter worth approximately $37,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other DaVita news, Director Barbara J. Desoer sold 5,030 shares of the stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $138.81, for a total value of $698,214.30. Following the completion of the sale, the director now directly owns 10,954 shares in the company, valued at $1,520,524.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.00% of the stock is currently owned by company insiders.
DaVita Trading Up 3.7 %
NYSE:DVA traded up $5.13 during mid-day trading on Tuesday, hitting $143.67. The company had a trading volume of 1,174,764 shares, compared to its average volume of 838,961. The firm has a market cap of $12.60 billion, a P/E ratio of 16.33, a P/E/G ratio of 1.06 and a beta of 1.04. DaVita Inc. has a fifty-two week low of $71.51 and a fifty-two week high of $145.04. The business's fifty day moving average is $135.40 and its two-hundred day moving average is $120.05. The company has a debt-to-equity ratio of 7.95, a quick ratio of 1.37 and a current ratio of 1.43.
DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $2.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.95 by $0.43. The firm had revenue of $3.07 billion during the quarter, compared to analysts' expectations of $3.03 billion. DaVita had a net margin of 6.61% and a return on equity of 68.52%. The business's revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.58 earnings per share. As a group, research analysts expect that DaVita Inc. will post 9.62 earnings per share for the current year.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on the stock. UBS Group boosted their price objective on shares of DaVita from $113.00 to $134.00 and gave the stock a "buy" rating in a research report on Wednesday, February 14th. TheStreet upgraded DaVita from a "c+" rating to a "b-" rating in a research report on Wednesday, February 7th. StockNews.com cut DaVita from a "strong-buy" rating to a "buy" rating in a report on Monday, May 6th. Barclays raised their target price on shares of DaVita from $133.00 to $150.00 and gave the company an "equal weight" rating in a research note on Monday, May 6th. Finally, Truist Financial boosted their price target on shares of DaVita from $135.00 to $150.00 and gave the stock a "hold" rating in a research note on Wednesday, May 15th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $144.67.
Check Out Our Latest Stock Analysis on DaVita
DaVita Profile
(Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Stories
- Five stocks we like better than DaVita
- Where Do I Find 52-Week Highs and Lows?
- GameStop Will Rocket Higher: The Move Won’t Last
- What is the FTSE 100 index?
- 3 Stocks Insiders are Buying That Should be on Your Radar
- Insider Buying Explained: What Investors Need to Know
- Momentum Investing: A Guide to Getting Started
→ 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad)
Should you invest $1,000 in DaVita right now?
Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
7 Energy Stocks to Buy and Hold Forever
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
